Hedge Fund - Paulson & Co

John Paulson Bio, Returns, AUM, Net Worth

Paulson & Co. is a New York-based fund management firm specializing in private equity and hedge funds founded in 1994. The firm is renowned for its expertise in event-driven arbitrage strategies, including merger arbitrage, bankruptcy reorganizations, and other corporate events. Paulson & Co. also pursues investments in distressed debt opportunities throughout the United States and Western Europe, leveraging its strategic insights and extensive market experience in these specialized areas of finance.

John Alfred Paulson is an American billionaire hedge fund manager, known as the founder and leader of Paulson & Co. Paulson's journey in finance began at New York University, where he returned in 1976 and excelled in his business studies. He graduated as valedictorian of his class with a summa cum laude distinction in finance from NYU's College of Business and Public Administration in 1978. Continuing his academic prowess, Paulson pursued an MBA at Harvard Business School as a George F. Baker Scholar, a prestigious recognition awarded to the top 5 percent of his class, supported by the Sidney J. Weinberg/Goldman Sachs scholarship, which he earned in 1980.

Paulson & Co. manages discretionary assets totaling $10,689,303,000, as reported in their Form ADV dated April 2020. With a client base of 20, the firm's latest 13F filing for Q1 2024 revealed $1,447,946,467 in managed 13F securities and a significant top 10 holdings concentration of 95.14%. Madrigal Pharmaceuticals Inc. stands as Paulson & Company's largest holding, with 1,775,000 shares held.

John Paulson
Fund Profile
Filing Period:
Fund Name: Paulson & Co
Manager John Paulson
Portfolio Value $1,353,006,722
Change This QTR +0.93%
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1.
Madrigal Pharmaceuticals Inc.
1,850,000 $518,296,000 +5% 38.3%
2. BSIG 8,950,121 $198,424,183 14.66%
3. BHC 26,439,035 $184,280,074 13.62%
4. PPTA 24,771,542 $128,812,018 9.52%
5. NG 27,238,061 $94,243,691 6.96%
News, Interviews and Investor Letters